Corporate News     08-Nov-22
Zydus receives USFDA final approval for Bisoprolol Fumarate and hydrochlorothiazide tablets
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to market Bisoprolol Fumarate and Hydrochlorothiazide tablets USP, 2.5 mg/6.25 mg, 5 mg/6.25 mg, 10 mg/6.25 mg (USRLD: Ziac® tablets).

Bisoprolol Fumarate and hydrochlorothiazide combination is indicated to treat high blood pressure (hypertension). The drug will be manufactured at the group's formulation manufacturing facility at Ahmedabad SEZ, India.

Bisoprolol Fumarate and Hydrochlorothiazide tablets had annual sales of USD 27.1 mn in the United States according to IQVIA data (IQVIA MAT Sep 2022).

Previous News
  Zydus Life inks exclusive licensing & supply agreement for Palbociclib Tablets with Synthon
 ( Hot Pursuit - 19-Jan-24   09:46 )
  Zydus Lifesciences Ltd soars 0.37%, rises for fifth straight session
 ( Hot Pursuit - 14-Feb-24   13:00 )
  Zydus Life declines after US FDA concludes manufacturing facility inspection with 10 observations
 ( Hot Pursuit - 24-Apr-24   13:24 )
  Zydus Life rises after receiving EIR report for Ahmedabad-based facility from US FDA
 ( Hot Pursuit - 13-Sep-23   13:47 )
  Indices trade near flat line; Media shares rally
 ( Market Commentary - Mid-Session 18-May-24   10:32 )
  Zydus Lifesciences receives USFDA approval for Tadalafil Tablets
 ( Corporate News - 07-Jun-23   15:45 )
  Zydus Lifesciences Ltd gains for third straight session
 ( Hot Pursuit - 02-Jan-24   13:05 )
  Zydus Lifesciences receives USFDA approval for Febuxostat tablets
 ( Corporate News - 10-Jan-23   15:05 )
  Zydus partners with Lupin to market Saroglitazar Mg in India
 ( Corporate News - 03-Nov-23   14:46 )
  Zydus Life gets USFDA nod for cystic acne drug
 ( Hot Pursuit - 31-Aug-23   13:24 )
  Zydus Life rises as Q2 PAT soars 53% YoY to Rs 801 cr
 ( Hot Pursuit - 07-Nov-23   15:23 )
Other Stories
  Board of Delhivery approves alteration in capital clause of MoA
  05-Jul-24   19:32
  J B Chemicals & Pharmaceuticals appoints director
  05-Jul-24   19:30
  Infosys announces resignation of senior management personnel
  05-Jul-24   19:22
  JLR Q1 FY25 retail sales up 9% on YoY basis
  05-Jul-24   19:08
  Bajaj Auto launches world's first CNG motorcycle 'Freedom'
  05-Jul-24   18:59
  Agenda for board meeting of Power Grid Corporation of India
  05-Jul-24   18:46
  Board of Bank of Baroda approves raising additional capital up to Rs 7,500 cr in FY25
  05-Jul-24   18:06
  Vipul to hold board meeting
  05-Jul-24   17:15
  Markobenz Ventures to convene board meeting
  05-Jul-24   17:15
  Dhanashree Electronics to declare Quarterly Result
  05-Jul-24   17:15
Back Top